BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24760015)

  • 1. Fetal exposure to perfluorinated compounds and attention deficit hyperactivity disorder in childhood.
    Ode A; Källén K; Gustafsson P; Rylander L; Jönsson BA; Olofsson P; Ivarsson SA; Lindh CH; Rignell-Hydbom A
    PLoS One; 2014; 9(4):e95891. PubMed ID: 24760015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.
    Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
    Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of maternal and fetal exposure and temporal trends of perfluorinated compounds.
    Ode A; Rylander L; Lindh CH; Källén K; Jönsson BA; Gustafsson P; Olofsson P; Ivarsson SA; Rignell-Hydbom A
    Environ Sci Pollut Res Int; 2013 Nov; 20(11):7970-8. PubMed ID: 23436123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls.
    Maisonet M; Terrell ML; McGeehin MA; Christensen KY; Holmes A; Calafat AM; Marcus M
    Environ Health Perspect; 2012 Oct; 120(10):1432-7. PubMed ID: 22935244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age.
    Hoffman K; Webster TF; Weisskopf MG; Weinberg J; Vieira VM
    Environ Health Perspect; 2010 Dec; 118(12):1762-7. PubMed ID: 20551004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey.
    Melzer D; Rice N; Depledge MH; Henley WE; Galloway TS
    Environ Health Perspect; 2010 May; 118(5):686-92. PubMed ID: 20089479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants.
    Okada E; Sasaki S; Saijo Y; Washino N; Miyashita C; Kobayashi S; Konishi K; Ito YM; Ito R; Nakata A; Iwasaki Y; Saito K; Nakazawa H; Kishi R
    Environ Res; 2012 Jan; 112():118-25. PubMed ID: 22030285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine exposure to perfluorinated compounds and overweight at age 4: A case-control study.
    Martinsson M; Nielsen C; Björk J; Rylander L; Malmqvist E; Lindh C; Rignell-Hydbom A
    PLoS One; 2020; 15(3):e0230137. PubMed ID: 32176721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal exposure to perfluorinated chemicals and behavioral or coordination problems at age 7 years.
    Fei C; Olsen J
    Environ Health Perspect; 2011 Apr; 119(4):573-8. PubMed ID: 21062688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study.
    Vélez MP; Arbuckle TE; Fraser WD
    Hum Reprod; 2015 Mar; 30(3):701-9. PubMed ID: 25567616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study.
    Whitworth KW; Haug LS; Baird DD; Becher G; Hoppin JA; Skjaerven R; Thomsen C; Eggesbo M; Travlos G; Wilson R; Cupul-Uicab LA; Brantsaeter AL; Longnecker MP
    Am J Epidemiol; 2012 Jun; 175(12):1209-16. PubMed ID: 22517810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: The HOME study.
    Vuong AM; Webster GM; Yolton K; Calafat AM; Muckle G; Lanphear BP; Chen A
    Environ Res; 2021 Apr; 195():110825. PubMed ID: 33545124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal Exposure to Perfluoroalkyl Acids and Serum Testosterone Concentrations at 15 Years of Age in Female ALSPAC Study Participants.
    Maisonet M; Calafat AM; Marcus M; Jaakkola JJ; Lashen H
    Environ Health Perspect; 2015 Dec; 123(12):1325-30. PubMed ID: 26034840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age.
    Stein CR; Savitz DA
    Environ Health Perspect; 2011 Oct; 119(10):1466-71. PubMed ID: 21665566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of Prenatal Exposure to Perfluorinated Chemicals with Maternal Essential and Long-Chain Polyunsaturated Fatty Acids during Pregnancy and the Birth Weight of Their Offspring: The Hokkaido Study.
    Kishi R; Nakajima T; Goudarzi H; Kobayashi S; Sasaki S; Okada E; Miyashita C; Itoh S; Araki A; Ikeno T; Iwasaki Y; Nakazawa H
    Environ Health Perspect; 2015 Oct; 123(10):1038-45. PubMed ID: 25840032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal levels of perfluorinated chemicals and subfecundity.
    Fei C; McLaughlin JK; Lipworth L; Olsen J
    Hum Reprod; 2009 May; 24(5):1200-5. PubMed ID: 19176540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association of Prenatal Exposure to Perfluorinated Chemicals with Glucocorticoid and Androgenic Hormones in Cord Blood Samples: The Hokkaido Study.
    Goudarzi H; Araki A; Itoh S; Sasaki S; Miyashita C; Mitsui T; Nakazawa H; Nonomura K; Kishi R
    Environ Health Perspect; 2017 Jan; 125(1):111-118. PubMed ID: 27219028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.